KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Diluted Average): 2011-2024

Historic Shares Outstanding (Diluted Average) for Emergent BioSolutions (EBS) over the last 12 years, with Dec 2024 value amounting to $53.0 million.

  • Emergent BioSolutions' Shares Outstanding (Diluted Average) rose 1.98% to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 1.98%. This contributed to the annual value of $53.0 million for FY2024, which is 3.52% up from last year.
  • As of FY2024, Emergent BioSolutions' Shares Outstanding (Diluted Average) stood at $53.0 million, which was up 3.52% from $51.2 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Shares Outstanding (Diluted Average) ranged from a high of $54.1 million in FY2021 and a low of $50.1 million during FY2022.
  • In the last 3 years, Emergent BioSolutions' Shares Outstanding (Diluted Average) had a median value of $51.2 million in 2023 and averaged $51.4 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Shares Outstanding (Diluted Average) decreased by 7.39% in 2022, and later grew by 3.52% in 2024.
  • Emergent BioSolutions' Shares Outstanding (Diluted Average) (Yearly) stood at $53.8 million in 2020, then rose by 0.56% to $54.1 million in 2021, then decreased by 7.39% to $50.1 million in 2022, then climbed by 2.20% to $51.2 million in 2023, then rose by 3.52% to $53.0 million in 2024.